跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 46,429 条关于
“Mezzion Pharmaceuticals, Inc.”
全部
46,429
临床试验
11,600
药物
3,157
机构
7,497
资讯
24,175
去年
Mezzion Secures $20 Million to Advance Phase 3 Trial of Udenafil for Rare Congenital Heart Disease
4个月前
Mezzion Secures Strategic Financing to Advance Phase 3 Trial of Udenafil for Fontan Circulation
9个月前
Mezzion Secures Key U.S. Patent for Udenafil in Fontan Patients, Extending Exclusivity to Early 2040s
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
上个月
Mezzion Reports Positive In Vivo Results for PDE5 Inhibitor Udenafil in ADPKD, Plans Phase 2b Trial
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Jazz Pharmaceuticals Advances Pipeline with Zanidatamab BLA Acceptance and Strong Financial Performance
去年
Syros Pharmaceuticals Announces SELECT-MDS-1 Trial Update and Strategic Realignment
去年
Acumen Pharmaceuticals Advances Sabirnetug for Alzheimer's, Reports Q3 2024 Financials
第 1 页，共 2418 页
上一页
下一页
